Position statement from the International Society for Prenatal Diagnosis on the use of non‐invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies

Citations Over TimeTop 1% of 2023 papers

Abstract

Key points What is already known about this topic? In 2015, the International Society for Prenatal Diagnosis (ISPD) published its first position statement on the use of non‐invasive prenatal testing (NIPT) to screen for aneuploidy. Widespread uptake across the globe and subsequent published research has shed new light on test performance and implementation issues. What does this study add? This new position statement replaces the 2015 statement with updated information on the current technologies, clinical experience, and implementation practices. As an international organization, ISPD recognizes that there are important population‐specific considerations in the organization of prenatal screening and diagnosis. These opinions are designed to apply to high income settings where prenatal screening for aneuploidy is an established part of antenatal care. This position statement is not a clinical practice guideline but represents the consensus opinion of the current ISPD Board based on the current state of knowledge and clinical practice.

Related Papers

• [The guideline for the treatment of mood disorders in USA and Japan].(2001)
• → Chapters 6-7(2003)1 cited
• INTRODUCING AN OPERATIVE AND SUPERVISION GUIDELINE FOR HIP FRACTURE SURGERY REDUCED THE RATE OF RE-OPERATION FROM 15% TO 10%(2010)
• [Verification of guideline for gastric cancer treatment based on a questionnaire].(2004)
• Effects of the Guideline of Community-aquired Pneumonia on the Achievement Ratio of CAP Therapy(2011)